BPC-157 / TB-500 Blend – Synergistic Peptide Stack for Regeneration Research

Intro Paragraph (Keyword Rich)
This advanced BPC-157 / TB-500 blend combines two of the most studied regenerative peptides in a single, convenient vial. Each lyophilized preparation contains 5mg Body Protection Compound-157 and 5mg Thymosin Beta-4 Fragment (TB-500), creating a research-grade synergistic stack ideal for studies involving accelerated tissue repair, fibroblast migration, and extracellular matrix remodeling. This pre-formulated combination eliminates dosing variability while ensuring precise 1:1 ratio consistency for reproducible laboratory results.

Synergistic Research Mechanisms

When studied together, BPC-157 and TB-500 demonstrate complementary pathways in wound healing research. While BPC-157 primarily modulates nitric oxide synthesis and upregulates growth hormone receptors, TB-500 (Ac-SDKP sequence) regulates actin polymerization and cellular migration. Research suggests this combination may enhance angiogenesis and collagen deposition more effectively than individual compounds alone, making this blend essential for advanced musculoskeletal and dermal regeneration studies.

Note: Strictly for in-vitro research and analytical purposes. Not for human or animal consumption.

 Product Specifications

• Composition: BPC-157 (5mg) + TB-500 (5mg) per vial
• Total Peptide Content: 10mg lyophilized powder
• BPC-157 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
• TB-500 Sequence: Ac-Ser-Asp-Lys-Pro-OH (Thymosin Beta-4 active fragment)
• Purity: ≥99% (HPLC verified for both constituents)
• Form: White crystalline lyophilized powder
• Solubility: Readily soluble in bacteriostatic water
• Storage: -20°C stable (lyophilized), 2-8°C after reconstitution

 Advantages of the Blend vs. Separate Administration

Researchers choose this BPC-157 TB-500 stack for protocol simplification and ratio precision. Pre-mixed formulations eliminate the risk of cross-contamination between individual vials while ensuring exact 1:1 stoichiometry in every administration. This consistency proves crucial for longitudinal studies requiring standardized dosing matrices across multiple test groups.

For single-compound studies, consider our standalone BPC-157 5mg or TB-500 5mg research peptides.

 Reconstitution & Preparation

Reconstitute this peptide blend with 2ml of bacteriostatic water to achieve a concentration of 2.5mg/ml per peptide (5mg/ml total). This concentration allows for flexible volumetric adjustments while maintaining peptide stability. Gently inject the solvent down the vial walls—avoid direct stream contact with the lyophilized cake to prevent peptide denaturation.

Required for preparation: Bacteriostatic Water 30ml | Sterile Insulin Syringes

 Storage Protocols

The BPC-157 TB-500 combination requires strict temperature control. Lyophilized vials maintain stability for 18-24 months at -20°C. Once reconstituted, the solution remains viable for 7-10 days refrigerated at 2-8°C. Due to the dual-peptide complexity, avoid freeze-thaw cycles of reconstituted solution to prevent aggregation or sequence degradation.

 Research Applications

• Tendon-to-bone healing velocity studies
• Fibroblast proliferation assays
• Angiogenesis model development
• Soft tissue injury modeling
• Extracellular matrix synthesis research

standalone BPC-157 5mg

BPC-157/TB-500 is a research compound in lyophilized powder form for laboratory research, testing, and analytical applications.

• Compound: BPC-157/TB-500

• Quantity: 10 mg

• Purity: ≥99% (HPLC Certified)

• Form: Lyophilized powder

• Appearance: White to off-white powder

• Solubility: Soluble in laboratory-grade sterile water

• COA: Included in product image gallery